First-in-Human Safety Study for Fractomer™ Biomatrix

Clinical trial NCT07151638 · SUSPENDED

Trial details

NCT number: NCT07151638
Sponsor: inSoma Bio, Inc.
Status: SUSPENDED
Phase: Not Applicable
Study type: INTERVENTIONAL

Soft Tissue Soft Tissue Defects Subcutaneous Injection

Start date: 2025-08-11
Primary completion: 2026-12-22
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.